Abstract
It is said that all good things must come to an end. The paper “Genomic heterogeneity of multiple synchronous lung cancer” by Liu et al . may finally close the book on the Martini and Melamed criteria for establishing whether multiple synchronous lung cancers (MSLC) represent distinct primary tumors or intrapulmonary metastases (1).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
